Clinical trial
A Clinical Study to Assess the Barrier Impact of Winlevi
NCT06415292 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Assess the Barrier Impact of Winlevi
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 27, 2023
- Completion date
- December 16, 2023
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.